Scalper1 News
Big drugmakers Amgen (AMGN) and Allergan (AGN) announced Wednesday that their biosimilar version of Roche’s (RHHBY) blockbuster cancer drug Avastin succeeded in a late-stage trial against non-small-cell lung cancer. Amgen and Allergan, which started their collaboration back in 2011 when Allergan was a generic drug maker called Watson Pharmaceuticals, released few details but said the drug ABP 215 had shown clinical equivalence to Avastin as Scalper1 News
Scalper1 News